For instance, within the NF-κB signaling pathway, we observed significant downregulation of DEGs such as Tnf and Il1b, which are key pro-inflammatory cytokines known to drive neuroinflammation in MS. This evidence concerns the gene IL1B and myeloid sarcoma.